Rod cells manage dim-light vision, cone cells handle daylight and colour, and ‘rod-cone dystrophy’ is simply a name for whichever group breaks down first. In this pattern it is the rods that fail first, with cone involvement joining only later — and that sequence is exactly what places most classic cases of retinitis pigmentosa within this category. It carries genuine clinical weight because it predicts, with reasonable consistency, which visual abilities fade earliest and which hold on the longest.
For a patient from Zambia who arrives with this precise term already written on a referral, understanding that rod-first sequence removes a lot of the guesswork from the very first conversation onward.
10+
years Experience
years Experience
5000+
Patients treated
Patients treated
100+
Countries served
Countries served
NABH
Guided facility
Guided facility
Ocular Symptoms
With the rods giving out first, difficulty seeing at night and a gradually shrinking field of vision tend to dominate the early and middle stages, while central vision and colour perception generally stay steady through that same window — only beginning to decline later, once the cones become involved as well. Many patients describe the change less as blurring and more as their surroundings slowly closing in from the sides
Underlying Causes
The rod-first pattern is rooted in mutations affecting genes that matter disproportionately to rod cell survival, which accounts for much of the genetic overlap with the broader RP category. Inheritance may follow a dominant, recessive, or X-linked pattern depending on which gene is at fault, and the condition can occur alone or as one feature within a wider syndrome touching other organ systems.
Diagnosis for Zambian Patients
Electroretinography does most of the work in separating rod-cone dystrophy from its mirror-image counterpart, cone-rod dystrophy: here, the rod-driven signal comes back noticeably weaker than the cone-driven signal, particularly in earlier stages. Visual field testing charts how far the peripheral loss extends, while OCT shows how much of the photoreceptor layer is still intact.
Meet The Team
Our Eye Specialists
Dr. Pawan
Associate Professor, Vitreo-Retina Surgeon. 10+ Years Experience
Retinal disorders, diabetic retinopathy, and advanced retina procedures. Provides diagnostic evaluation and treatment planning for international patients.
Dr.Pallavee
Senior Consultant Ophthalmologist & Eye Surgeon· 26+ yrs experience
Areas of Focus: Cataract surgery, corneal disorders, refractive procedures, and glaucoma management. Provides comprehensive eye care and surgical expertise for global patients.
Dr. Robin
Consultant Ophthalmologist & Eye Surgeon, MD, DO .16+ Years Experience
Areas of Focus: Cataract surgery, corneal disorders, refractive procedures, and glaucoma management. Provides comprehensive eye care and surgical expertise for global patients.
Treatment Approach in India
Care follows the same regenerative and supportive framework used across the progressive dystrophies — stem cell therapy is evaluated for patients whose test results suggest they are reasonable candidates, paired with practical guidance for adjusting to reduced night and peripheral vision while central vision remains comparatively stable for longer.
Reviews
What Our Patients Say
DR NAAGALAKSHMI R
1 week ago
Asha Babbar
2 weeks ago
The overall experience at the RP Treatment Center was very good. The staff was supportive and caring, and we provided proper attention and guidance during treatment. The environment at the center was clean and comfortable. The doctors and staff tried to understand patients' needs and explained the treatment process well.
Overall, I am satisfied with the service and care. Highly recommended!
Overall, I am satisfied with the service and care. Highly recommended!
Harshita Kapoor
2 weeks ago
Life‑Changing Experience with RP Therapy”
After years of struggling with vision loss due to Retinitis Pigmentosa, I finally found hope here. The doctors were highly professional, explained the stem cell treatment in detail, and gave me confidence at every step. The therapy was smooth, and I’ve already noticed positive changes in my daily life. Their dedication, care, and advanced medical approach make this center truly trustworthy
After years of struggling with vision loss due to Retinitis Pigmentosa, I finally found hope here. The doctors were highly professional, explained the stem cell treatment in detail, and gave me confidence at every step. The therapy was smooth, and I’ve already noticed positive changes in my daily life. Their dedication, care, and advanced medical approach make this center truly trustworthy
Yash Chauhan
2 weeks ago
I had a really good experience at RP Treatment Centre. The doctor listened to my problem patiently and explained the treatment in a simple way. The staff was polite and the clinic was clean. I started feeling better after the treatment. Highly recommended!
pragya chauhan
2 weeks ago
Very satisfied with the service. The doctor is experienced and gives proper attention to every patient. The staff is friendly, and the overall environment is comfortable. Thank you, RP Treatment Centre, for the excellent care.
Manisha kapoor
2 weeks ago
I had been struggling with Retinitis Pigmentosa for years, and finding this center was truly life‑changing. The doctors provided a thorough medical evaluation and explained every step of the stem cell therapy process with clarity. The treatment was smooth, professional, and I noticed encouraging improvements in my vision within weeks. Their continuous follow‑up care and compassionate support made me feel confident throughout the journey. Highly recommended for anyone seeking advanced RP treatment in India.
Frequently Asked Questions
Is rod-cone dystrophy simply another term for RP?
“There is considerable overlap between the two. ‘Rod-cone dystrophy’ describes the order the disease follows — rods first, cones later — and that particular order applies to most cases that end up clinically labelled retinitis pigmentosa.”
What actually separates rod-cone from cone-rod dystrophy?
”
It comes down to which cell type fails first. Rod-cone dystrophy affects night and peripheral vision early while central and colour vision hold up longer; cone-rod dystrophy runs the reverse course, with central and colour vision affected sooner.”
Will my central vision eventually be affected too?
” In many rod-cone cases, eventually yes — central vision can decline once the disease has progressed far enough to reach the cones, though the timeline for that shift varies considerably by gene and by individual patient.”
How often will follow-up monitoring be required?
“That is decided on a case-by-case basis, guided by how quickly ERG and field results shift after the initial evaluation. Some patients only need annual review, while others with a faster-moving pattern are seen more frequently.”
